IL-6, which shows the highest increase of >70-fold in xenografted versus the control plasma, has been shown to promote a microenvironment conducive to tumor growth (Hirano, 2021; Taniguchi and Karin, 2014). This evidence concerns the gene IL6 and neoplasm.